Citadel Advisors’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.73M Buy
+145,900
New +$2.78M ﹤0.01% 5450
2025
Q4
Sell
-37,600
Closed -$1.01M 14015
2025
Q3
$1.01M Sell
37,600
-37,400
-50% -$892K ﹤0.01% 7524
2025
Q2
$1.26M Sell
75,000
-27,100
-27% -$478K ﹤0.01% 6596
2025
Q1
$1.8M Buy
102,100
+61,900
+154% +$1.24M ﹤0.01% 5729
2024
Q4
$976K Sell
40,200
-108,700
-73% -$3.1M ﹤0.01% 7075
2024
Q3
$5.53M Buy
148,900
+120,600
+426% +$4.5M ﹤0.01% 3784
2024
Q2
$1.35M Sell
28,300
-84,600
-75% -$3.71M ﹤0.01% 6046
2024
Q1
$4.32M Buy
112,900
+27,700
+33% +$901K ﹤0.01% 4169
2023
Q4
$2.66M Buy
85,200
+44,900
+111% +$1.61M ﹤0.01% 4864
2023
Q3
$1.62M Sell
40,300
-9,700
-19% -$454K ﹤0.01% 5603
2023
Q2
$2.63M Buy
50,000
+5,100
+11% +$311K ﹤0.01% 4683
2023
Q1
$2.87M Sell
44,900
-3,800
-8% -$248K ﹤0.01% 4711
2022
Q4
$2.36M Sell
48,700
-180,400
-79% -$11.3M ﹤0.01% 5162
2022
Q3
$16.2M Buy
229,100
+151,600
+196% +$13M ﹤0.01% 2125
2022
Q2
$5.5M Buy
77,500
+16,700
+27% +$1.08M ﹤0.01% 3617
2022
Q1
$4.86M Sell
60,800
-7,800
-11% -$581K ﹤0.01% 4227
2021
Q4
$6.26M Sell
68,600
-5,800
-8% -$622K ﹤0.01% 3900
2021
Q3
$9.56M Buy
74,400
+7,700
+12% +$1.08M ﹤0.01% 3163
2021
Q2
$10.2M Sell
66,700
-6,000
-8% -$790K ﹤0.01% 3036
2021
Q1
$7.66M Sell
72,700
-6,000
-8% -$601K ﹤0.01% 3409
2020
Q4
$6.24M Buy
78,700
+12,900
+20% +$944K ﹤0.01% 3310
2020
Q3
$3.72M Sell
65,800
-9,200
-12% -$495K ﹤0.01% 3598
2020
Q2
$4.62M Buy
75,000
+9,700
+15% +$396K ﹤0.01% 3199
2020
Q1
$2.11M Buy
65,300
+35,100
+116% +$1.18M ﹤0.01% 4062
2019
Q4
$1.06M Buy
30,200
+17,100
+131% +$564K ﹤0.01% 5474
2019
Q3
$338K Sell
13,100
-13,900
-51% -$422K ﹤0.01% 7386
2019
Q2
$793K Hold
27,000
﹤0.01% 6085
2019
Q1
$923K Sell
27,000
-19,900
-42% -$704K ﹤0.01% 5730
2018
Q4
$1.5M Sell
46,900
-8,000
-15% -$312K ﹤0.01% 4634
2018
Q3
$2.63M Buy
54,900
+34,500
+169% +$1.41M ﹤0.01% 3944
2018
Q2
$632K Buy
+20,400
New +$477K ﹤0.01% 5992
2015
Q3
Sell
-2,300
Closed -$22K 9217
2015
Q2
$22K Buy
+2,300
New +$21.3K ﹤0.01% 8107
2015
Q1
Sell
-1,100
Closed -$10K 8831
2014
Q4
$10K Sell
1,100
-500
-31% -$4.84K ﹤0.01% 8138
2014
Q3
$17K Sell
1,600
-6,400
-80% -$76.1K ﹤0.01% 7562
2014
Q2
$134K Buy
8,000
+7,500
+1,500% +$123K ﹤0.01% 5969
2014
Q1
$9K Buy
+500
New +$8.05K ﹤0.01% 7545

Other funds holding STAA

Citadel Advisors's STAA Position: Q1 2026 in Review

Citadel Advisors increased its STAAR Surgical (STAA) stake by 416% in Q1 2026, buying an estimated $16.3M and bringing the position to 1,059,428 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

Citadel Advisors first reported a position in STAA in Q4 2013 and has held it in 39 quarters since. The position peaked at $38M in Q3 2023. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Citadel Advisors held 1,059,428 shares of STAAR Surgical worth $19.8M as of Q1 2026.
  • Citadel Advisors bought 854,309 STAAR Surgical shares in Q1 2026, an estimated $16.3M.
  • STAAR Surgical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2354 holding.
  • Citadel Advisors first reported a position in STAAR Surgical in Q4 2013 and has held it in 39 quarters since.
  • Citadel Advisors's STAAR Surgical position peaked at $38M in Q3 2023.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.